Witzig, T. E., Tomblyn, M. B., Misleh, J. G., Kio, E. A., Sharkey, R. M., Wegener, W. A. and Goldenberg, D. M. (2014) “Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma”, Haematologica. Pavia, Italy, 99(11), pp. 1738-1745. doi: 10.3324/haematol.2014.112110.